Joint & Platelet-Rich Plasma Injections

Joint Injections

Major and intermediate joint injections are injections of local anesthetic and steroid medication (anti-inflammatory) combination directly into a joint space or capsule where the two bones move together.

Procedure

The skin over the target joint(s) is cleaned with antiseptic solution. The doctor will then insert a needle into the targeted joint and inject the combination of medications.

  • Most patients can walk around immediately after a joint injection. After being monitored for short time, you can leave the facility.

  • Patients typically resume full activity the next day. Soreness around the injection site may be relieved by using ice or taking a mild analgesic.

  • Joint injections typically begin to work in about 3-5 days, and the effects can last from several days up to a few months. Sometimes, if desired relief is not achieved with the first injection, the doctor may recommend a second injection.

  • Commonly injected joints include: knees, hips, shoulders, ankles, elbows, wrists, base of the thumbs, and small joints in the hands and feet.

Platelet-Rich Plasma (PRP) Injections

The Liberty MTXTM System is designed for the safe and rapid preparation of Platelet-Rich Fibrin Matrix (PRFM) from a small sample of blood at the patient point of care. Many Platelet Rich Plasma (PRP) systems require operator skill, have varying results, and have extensive contamination with red blood cells and white blood cells. Liberty MTX™ removes virtually all contaminating cells and is independent of operator technique. PRP is converted to PRFM through a controlled process, creating a scaffold that serves to protect and preserve platelets. Think of Liberty MTX™ PRFM as the next-generation PRP.

The Carestream Process

  • Blood Draw

  • Centrifugation

  • Transfer

  • Application

Liberty MTX™ PRFM

  • "Golden" Visual Guide to Quality

  • Purest PRP/PRFM

  • Closed-System

  • Secondary Proprietary Step

  • Converts PRP to PRFM

  • Calcium chloride allows for controlled fibrin polymerization

  • Scaffold is a biologic connector

  • Platelets are localized and viable

  • Sustained growth factor release